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Abstract. 
 
Occludin is a transmembrane protein of 
the tight junction that functions in creating both an 
intercellular permeability barrier and an intramem-
brane diffusion barrier. Creation of the barrier re-
quires the precise localization of occludin, and a dis-
tinct family of transmembrane proteins called 
claudins, into continuous linear ﬁbrils visible by 
freeze-fracture microscopy. Conﬂicting evidence ex-
ists regarding the relative importance of the trans-
membrane and extracellular versus the cytoplasmic 
domains in localizing occludin in ﬁbrils. To speciﬁ-
cally address whether occludin’s COOH-terminal 
cytoplasmic domain is sufﬁcient to target it into tight 
junction ﬁbrils, we created chimeras with the trans-
membrane portions of connexin 32. Despite the gap 
junction targeting information present in their trans-
membrane and extracellular domains, these con-
nexin-occludin chimeras localized within ﬁbrils 
 
when expressed in MDCK cells, as assessed by immu-
noﬂuorescence and immunogold freeze-fracture imag-
ing. Localization of chimeras at tight junctions de-
pends on the COOH-terminal ZO-binding domain 
and not on the membrane proximal domain of occlu-
din. Furthermore, neither endogenous occludin nor 
claudin is required for targeting to ZO-1–containing 
cell–cell contacts, since in normal rat kidney ﬁbro-
blasts targeting of chimeras again required only the 
ZO-binding domain. These results suggest an important 
role for cytoplasmic proteins, presumably ZO-1, ZO-2, 
and ZO-3, in localizing occludin in tight junction ﬁbrils. 
Such a scaffolding and cytoskeletal coupling function 
for ZO MAGUKs is analogous to that of other mem-
bers of the MAGUK family.
Key words: tight junction • occludin • connexin 32 • 
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T
 
he
 
 tight junction provides a continuous band of
cell–cell contact that seals the paracellular space, al-
lowing separation of apical and basal fluid compart-
ments. It also defines apical and basal membrane polarity
by restricting lipid and protein diffusion in the bilayer
(Dragsten et al., 1981; van Meer and Simons, 1986). In
transmission electron micrographs, the tight junction ap-
pears as a series of focal membrane contacts. By freeze-
fracture electron microscopic analysis, contacts appear as
either continuous fibrils or rows of particles (depending on
the fixation conditions) that partition with either the
 
 
 
pro-
toplasmic
 
 
 
(P-face)
 
1
 
 leaflet or the ectoplasmic leaflet of the
membrane fracture plane. These fibrils and particles have
been shown to contain occludin and members of the clau-
din family (Fujimoto, 1995; Furuse et al., 1996, 1998a). It is
important to determine the mechanism for targeting and
organizing occludin in fibrils, since this intricate architec-
ture is presumably required to form a continuous barrier.
Several proteins have been localized to a cytoplasmic
plaque underlying the tight junction fibrils, either by im-
munohistochemistry or by virtue of binding to known tight
junction proteins (for review see Balda et al., 1998). It is
likely that, to some extent, the organization of occludin
into fibrils depends on this underlying plaque. Specifically,
occludin binds (ZO-1)
 
 
 
(Stevenson et al., 1986; Willott et
al., 1993), ZO-2 (Jesaitis and Goodenough, 1994) and
ZO-3 (Haskins et al., 1998), members of a family of
membrane-associated signaling proteins termed the mem-
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brane-associated guanylate kinase (MAGUK) superfam-
ily. Several other MAGUK proteins have been shown to
cluster ion channels and receptors at specific membrane
domains and link these proteins to the cytoskeleton (for
review see Fanning and Anderson, 1998). By analogy, a
similar role exists for ZO family members at the tight junc-
tion.
Both occludin and the claudins, 65 kD and 
 
z
 
22 kD, re-
spectively, are predicted to span the membrane four times,
forming two extracellular loops with cytosolic NH
 
2
 
 and
COOH termini (Furuse et al., 1993, 1998a). This predicted
topology is similar to that of connexin and synaptophysin
and, in the case of occludin, has been confirmed by immu-
nomicroscopic studies (Furuse et al., 1993; Van Itallie and
Anderson, 1997). Although occludin is in tight junction
fibrils, it is not essential for their formation, as occludin
knockout embryonic stem cells still make claudin-contain-
ing fibrils and form intercellular diffusion barriers (Saitou
et al., 1998). Nonetheless, evidence indicates occludin is
normally a functional component of the junction. For ex-
ample, overexpression of occludin in cultured epithelial
cell monolayers results in an electrically tighter junction
(Balda et al., 1996), and overexpression of truncated oc-
cludin disrupts the electrical barrier (McCarthy et al.,
1996; Bamforth et al., 1999). Similarly, brain endothelial
cells that form the impermeable blood–brain barrier ex-
press high levels of occludin, whereas endothelial cells in
nonneural tissues, which have leakier tight junctions, ex-
press lower levels of occludin (Hirase et al., 1997).
Recent studies suggest that the structural basis for oc-
cludin’s sealing properties may arise from the ability of
this protein to form adhesive contacts with proteins on ad-
jacent cells. Addition of a peptide comprising occludin’s
second extracellular loop to a cultured epithelial mono-
layer results in a loss of occludin at the membrane and
subsequent disruption of ion and macromolecule selectiv-
ity (Wong and Gumbiner, 1997). A second study has
shown that occludin can mediate intercellular adhesion,
suggesting that adhesion may be required to form the in-
tercellular seal. Transfection of occludin null fibroblasts
with occludin confers Ca
 
2
 
1
 
-independent cell adhesion,
which can be competed for by peptides corresponding to
the extracellular loops (Van Itallie and Anderson, 1997).
It is likely that occludin mediates this interaction through
homophillic interactions (Furuse et al., 1998b).
Recent studies suggest at least two distinct, but not ex-
clusive, mechanisms for occludin targeting and localization
at the tight junction. First, transmembrane or extracellular
regions of occludin may self-associate and/or associate
with claudins and provide an anchor for cytoplasmic pro-
teins, transducing an instructive signal to assemble the
plaque. This is similar to the proposed mechanism by
which cadherin nucleates the adherens junction or inte-
grins nucleate focal contacts. Alternately, organizational
information from a cytoplasmic protein such as ZO-1 may
recruit and tether occludin in fibrils at the junction.
In support of the first model, two studies reported that
occludin lacking the COOH-terminal cytoplasmic tail lo-
calized at the tight junction when expressed in MDCK
cells. Balda et al. (1996) demonstrated that chicken occlu-
din constructs lacking the entire COOH-terminal tail lo-
calize at tight junctions in MDCK cells, although in a dis-
continuous pattern. Similarly, a microinjected occludin
construct lacking almost the entire COOH terminus local-
ized at tight junctions in 
 
Xenopus
 
 embryos (Chen et al.,
1997). These results suggest the NH
 
2
 
-terminal half of
occludin is sufficient for localization. However, tail-less
occludin may localize by oligomerizing with a full-length oc-
cludin (Chen et al., 1997) that targeted because of an inter-
action with cytoplasmic proteins. More recently, Furuse et
al. (1998b) demonstrated that transfection of occludin
alone into L-cell fibroblasts is insufficient to form fibrils,
but that cotransfection with claudin-1 or -2 results in fibril
formation, suggesting that occludin–claudin interactions
may be necessary for occludin’s incorporation in fibrils.
Matter and Balda (1998) recently demonstrated that al-
though the COOH-terminal tail of occludin contains baso-
lateral targeting information, it is not sufficient to localize
Fc-occludin chimeras at the tight junction, again suggest-
ing that the NH
 
2
 
 terminus is responsible for tight junction
localization. Therefore, putative occludin–occludin or clau-
din–occludin interactions may occur via occludin’s mem-
brane-spanning domains. Thus, several studies support the
role of the membrane-spanning, amino half of occludin in
localization to tight junctions, and occludin self-oligomer-
ization or occludin–claudin co-oligomerization may pro-
vide an explanation for this requirement.
In contrast and in support of the second model, other
data have argued that the COOH-terminal tail of occludin
mediates tight junction targeting. Structural and functional
data suggest that the COOH-terminal tail (human occlu-
din residues 266–522) has at least two subdomains. A do-
main encompassing the COOH-terminal 150 amino acids
(here referred to as the distal or ZO-binding domain) is
highly charged, relatively conserved across species, and
binds directly to ZO-1 (Furuse et al., 1994), ZO-2 (Itoh et
al., 1999), and ZO-3 (Haskins et al., 1998). The second oc-
cludin tail domain, encompassing the 150–amino acids
proximal to the membrane (here referred to as the proxi-
mal domain), is not known to interact with other proteins.
This region is less charged and less conserved across spe-
cies than the distal domain (Ando-Akatsuka et al., 1996).
Furuse et al. (1994) reported that transfected chicken oc-
cludin constructs lacking the distal domain do not localize
at tight junctions in a bovine kidney cell line. Recently,
Bamforth et al. (1999) demonstrated that an NH
 
2 
 
termi-
nally truncated occludin missing three of its four trans-
membrane domains can still localize at tight junctions in a
mouse submandibular cell line. Furthermore, full-length
occludin localizes at ZO-1 containing sites of cell–cell con-
tact in the normal rat kidney (NRK) fibroblast cell line
(Van Itallie and Anderson, 1997) NRKs lacks endogenous
occludin and, presumably, claudins, thereby implicating
cytoplasmic plaque proteins not self-association, in the re-
cruitment of occludin to these sites.
These differing observations raise the following ques-
tion, what is the contribution of cytoplasmic plaque pro-
tein interactions in organizing occludin into the linear,
fibrillar structure of tight junctions? To address this ques-
tion, we constructed chimeric proteins containing the tail
of human occludin, with or without the region that binds
ZO proteins, fused to the membrane-spanning portions of
the gap junction protein rat connexin 32 (cx32). cx32 oligo-
merizes into connexons, which form extracellular homo- 
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typic contacts between adjacent cells. The information
that targets connexin 32 to the gap junction resides in the
NH
 
2
 
-terminal membrane-spanning half of the protein
(Leube, 1995), and has been shown in analogous studies to
be sufficient to target chimeric proteins to the gap junction
(Troyanovsky et al., 1993). We observed that chimeras
containing the ZO-binding domain of occludin target to
tight junction fibrils, even in the presence of this gap junc-
tion targeting information. We also investigated these chi-
meras in NRK fibroblasts to determine how the absence of
endogenous occludin and claudin family proteins affect
occludin targeting. MDCK cells contain occludin and at
least claudin 1, 2, and 3 and establish functional tight junc-
tions, whereas NRK cells do not contain occludin or clau-
din 1 or 2 (or, presumably, other claudin family members
because of the mesenchymal origins of NRKs) and do not
generate tight junctions. Again, we observed that the ZO-
binding domain of human occludin was sufficient to incor-
porate chimeras into ZO-1–containing sites of cell–cell
contact in NRK fibroblasts. These results demonstrate
that localization does not require occludin–occludin or oc-
cludin–claudin interactions. Further, these data suggest
that interactions with ZO MAGUK proteins contribute to
scaffolding occludin at the tight junction.
 
Materials and Methods
 
Plasmid cDNA Constructs
 
Plasmids containing cDNAs encoding either human occludin (Van Itallie
and Anderson, 1997) or cx32 (a gift of Dr. David Paul, Harvard Medical
School, Cambridge, MA) were used as templates in PCRs to construct chi-
meric cDNAs. All cloned PCR products were confirmed by dideoxy se-
quencing in both directions. The vesicular stomatitis virus glycoprotein
(VSV-G) epitope–tagged human occludin cDNA (HOC) has been de-
scribed previously (Van Itallie and Anderson, 1997). All constructs were
expressed in MDCK or NRK cells using the mammalian expression vector
pCB6 (Karl Matter, University of Geneva, Switzerland).
The connexin-occludin chimera (CX/OC) was constructed in three
steps. First, primers 19985 (5
 
9
 
-GTACTAGTAGGCAGGATGAACT-
GGACAGGT-3
 
9
 
) and 19984 (5
 
9
 
-ATCATCCGGGCCTGTGCCCGCG-
CGGCCGC-3
 
9
 
) were used to amplify the NH
 
2
 
-terminal 219-residues en-
compassing all four transmembrane regions of connexin 32 using Vent
polymerase (New England Biolabs Inc.). The product was digested with
Spe1 and Not1 and cloned into pSK-Bluescript (Stratagene). Second, using
primers 19983 (5
 
9
 
-CGCGGCCGCGAAAACTCGAAGAAAGATG-
GAC-3
 
9
 
) and 19986 (5
 
9
 
-GACTATGATAGACAGAAAACAGCCTAC-
ACCGACATCGAGATGAACAGGCTGGGCAAGTGAGAGCTC-3
 
9
 
),
the entire COOH-terminal cytoplasmic tail of occludin was amplified and
a VSV-G tag was added. The resulting fragment was digested with NotI
and SacI and inserted into pSK-Bluescript. Third, PCR products were
subsequently excised and ligated into pCB6.
The distal COOH-terminal residues of occludin (DOC) chimera were
made by ligating the transmembrane region of connexin 32 (generated via
primers 19985 and 19984 as described above) to the distal 150 amino acids
of occludin (residues 373–522), as amplified and VSV-G tagged using
primer 19986 combined with 21063 (5
 
9
 
-CGCGGCCGCGAACTTTGA-
GACAGGTTGAAAAACA-3
 
9
 
). The resulting fragments were digested as
above and subcloned as above into pCB6.
The proximal residues 266–372 of the occludin cytoplasmic tail (POC)
chimera were made by ligating the transmembrane region of connexin 32
(generated via primers 19985 and 19984 as described above) to the mem-
brane proximal portion of the occludin tail (residues 266–372), which was
amplified and VSV-G tagged using primers 19983 and 24008 (5
 
9
 
-
CCTCGTTACAGCAGCGGTGGTGCCTACACCGACATCGAGAT-
GAACAGGCTGGGCAAGTGAGGATCC-3
 
9
 
). The resulting frag-
ments were digested with SpeI, NotI and NotI, and BamHI, respectively,
and subcloned into pCB6.
 
Cell Culture and Generation of Stable Lines
 
MDCK and NRK cells were obtained from the American Type Culture
Collection and grown in DME supplemented with 10% FBS (Atlanta Bio-
logicals), 5 mM L-glutamine (GIBCO BRL), 5 mM penicillin, and 5 U/ml
streptomycin, hereafter known as DME-complete.
To generate MDCK cells stably expressing the constructs, cells were
transfected via lipofection (GIBCO BRL) or calcium-phosphate coprecip-
itation (Chen and Okayama, 1988) and selected using DME-complete
containing 0.8 mg/ml G418 (GIBCO BRL). Resistant colonies were iso-
lated and maintained in DME-complete containing 0.25 mg/ml G418.
 
Transient DNA Transfections and Immunofluorescence
 
cDNAs were introduced transiently into NRK cells plated on coverslips
by calcium phosphate coprecipitation (Chen and Okayama, 1988). MDCK
clones stably expressing chimeric proteins were plated on coverslips and
cultured 2–6 d before being fixed. 12–16 h after transient transfection,
NRK cells were fixed and prepared for immunofluorescence as described
in Fanning et al. (1998). VSV-G–tagged constructs were detected with a
rabbit polyclonal anti–VSV-G antibody (MBL Laboratories) or mouse
mAb P5D4 (a gift of Dr. Thomas Kreis, University of Geneva, Switzer-
land), both used at 1:200. To visualize the endogenous ZO-1, cells were la-
beled using rat mAb 40.76 (Stevenson et al., 1986) or a rabbit polyclonal
antibody 4476 (Zymed Labs, Inc.). Rat connexin 32 was visualized with
mouse mAb M12.13 (a gift of Dr. David Paul, Harvard Medical School,
Cambridge, MA) or mouse anti–rat connexin 32 mAb (Chemicon Interna-
tional, Inc.). For epifluorescent microscopy, labeling was visualized using a
Nikon Microphot FX microscope with a 60
 
3
 
 PlanApo objective and im-
ages were captured using either T-MAX 400 film or a Sensys cooled CCD
camera (Photometrics). These images were processed using Adobe Photo-
shop 4.0 or Image Pro Plus 2.0 (Media Cybernetics), respectively.
 
SDS-digested Freeze-Fracture Replica Labeling 
Electron Microscopy
 
MDCK cells were plated in 10-cm diameter tissue culture plates and
grown to confluence. Cells were fixed in 1% paraformaldehyde in Dul-
becco’s phosphate-buffered saline (DPBS) for 15 min at 4
 
8
 
C for SDS-
digested freeze-fracture replica labeling or in 2% glutaraldehyde in 0.1 M
cacodylate buffer, pH 7.4, for 30 min at 4
 
8
 
C for conventional freeze-frac-
ture. The cells were washed in the respective buffers, scraped from the
substrate with a plastic cell scraper and infiltrated with graded amounts of
glycerol in 0.1 M cacodylate buffer for 50 min at 4
 
8
 
C. Cell pellets were frozen
in liquid nitrogen slush and freeze-fractured at 
 
2
 
115
 
8
 
C in a Balzers 400
freeze-fracture unit (Balzers, Liechtenstein). SDS digestion and immunola-
beling of replicas with polyclonal anti–VSV-G antibody (1:50 or 1:100) fol-
lowed by protein A gold (10 nm) was performed as described (Fujimoto,
1995). Replicas were examined using a Philips 301 electron microscope.
To quantitate gold particle distribution on micrographs, the distance
from the center of a gold particle to the center of the nearest fibril was
measured on photographic enlargements of micrographs using dial cali-
pers (Small Parts, Inc.) that accurately measure in increments of 0.02 mm.
The number of junctions and gold particles analyzed was as follows: 13
junctions and 343 gold particles for HOC, 8 junctions and 735 gold parti-
cles for CX/OC, and 2 junctions and 9 gold particles for control cells. The
distance of a gold particle from fibril versus the number of occurrences
was plotted using Microsoft Excel.
 
Results
 
To investigate the role of the cytoplasmic COOH-terminal
domain of occludin in targeting occludin, we fused regions
of the tail of human occludin to the membrane-spanning
portions of rat connexin 32 (cx32). Occludin and cx32 share
similar membrane topogenics, with each predicted to form
two extracellular loops, four transmembrane helices, and
NH
 
2
 
 and COOH cytoplasmic termini. Fig. 1 illustrates con-
structs used in this study. An 11–amino acid tag from the
VSV-G protein was engineered at the COOH terminus of
each connexin-occludin construct to facilitate immunode-
tection. 
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MDCK and NRK cells do not express detectable
amounts of rat cx32, as determined by immunofluores-
cence labeling and immunoblotting (data not shown), pro-
viding null backgrounds in which to introduce chimeric
proteins. Plasmids encoding chimeric proteins were trans-
 
fected into MDCK cells and multiple clones of each con-
struct were isolated by selection for G418 resistance.
Stably transfected cell lines used were morphologically in-
distinguishable from their untransfected counterparts. At
least three clones were analyzed for each experiment and
each showed results similar to the representative clones
reported in this study. NRK experiments reported in this
study were performed by transient transfection.
 
A Connexin-Occludin Chimera Localizes at Tight 
Junctions in MDCK Cells
 
We first investigated the membrane targeting characteris-
tics of full-length cx32 transfected into MDCK cells to
interpret the results of subsequent chimeric studies. Pub-
lished studies have shown that the NH
 
2
 
-terminal, membrane-
spanning half of cx32 contains information sufficient to
target to gap junctions (Leube, 1995). Indirect immunoflu-
orescence revealed that cx32 transiently transfected in
MDCKs localized in the typical punctate pattern of gap
junctions (Fig. 2 a). Protein was concentrated on the lat-
eral surfaces of transfected cells regardless of whether ad-
jacent cells also expressed cx32. Colabeling for ZO-1, a
protein highly concentrated at tight junctions, demon-
strated typical tight junction staining in a focal plane dis-
tinct from cx32 labeling (Fig. 2 b). Thus, rat liver cx32 clus-
ters in gap junctionlike structures on the lateral surface of
MDCKs and has no inherent ability to localize with ZO-1
at tight junctions.
Figure 1. Schematic illustration of constructs used. HOC and
cx32 contain four membrane-spanning domains (checked and
solid boxes) with cytoplasmic NH2 and COOH termini. Chimeric
proteins containing the NH2-terminal transmembrane regions of
cx32 fused to the entire COOH-terminal tail of occludin (CX/
OC), the membrane proximal residues 266–372 of occludin
(POC), or the distal COOH-terminal residues 373–522 of occlu-
din (DOC) are indicated. Only CX/OC and DOC include the
ZO-binding domain (thick striped box). VSV-G tagged chimeras
are indicated.
Figure 2. Immunofluorescent
localization of cx32 and CX/
OC in MDCK cells. cx32 lo-
calizes at gap junctionlike
puncta around the cell pe-
riphery (a) in a focal plane
basal to that of ZO-1 (b).
Cells stably expressing CX/
OC, visualized using poly-
clonal anti–VSV-G antibody,
localized it at tight junctions
(c), similar to endogenous
ZO-1 (d). Bar, 30 mm. 
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In contrast, when the COOH-terminal tail of cx32 was
replaced with the COOH-terminal tail of occludin to form
the CX/OC chimera (Fig. 1), VSV-G epitope immunola-
beling revealed that this chimera localized at tight junc-
tions and not solely at gap junctions, as might be expected
because of the gap junction targeting information in the
NH
 
2 
 
terminus (Fig. 2 c). VSV-G staining for CX/OC paral-
leled that of endogenous ZO-1 staining (Fig. 2 d), with
both colocalized in a reticular pattern around the apical
surface of cells. Note that expression of the chimera in ad-
jacent cells is not required for localization, as continuous,
circumferential VSV-G labeling is seen in cells adjacent to
untransfected neighbors. Interestingly, in clones express-
ing very low levels of CX/OC, the protein localized prima-
rily at tight junctions (as seen in Fig. 2 c), whereas clones
greatly overexpressing CX/OC localized it at both tight
 
and gap junctions (data not shown). These observations
may imply that the incorporation of CX/OC into tight
junctions is saturable, and that excess chimeric protein fol-
lows a default localization to gap junctions. Thus, the hu-
man occludin tail is sufficient to target chimeras containing
the transmembrane portions of rat cx32 to the tight junction,
even though the NH
 
2
 
-terminal half of cx32 possesses gap
junction targeting information. In addition, the NH
 
2 
 
-termi-
nal, membrane-spanning half of human occludin is not nec-
essary for occludin’s localization at the tight junction.
 
CX/OC Chimeras Are Incorporated into Tight
Junction Fibrils
 
To ask whether the CX/OC chimera was actually incor-
porated specifically into fibrils or simply concentrated around
Figure 3.  Freeze-fracture immunolabeling of CX/OC in MDCK cells. For SDS-digested freeze-fracture replica labeling electron mi-
croscopy, replicas of MDCK cells stably transfected with empty pCB6 vector (a), HOC (b), or CX/OC (c and d) were fixed in 1%
paraformaldehyde, reacted with anti–VSV-G polyclonal antibody and labeled with 10 nm protein A gold as described in Materials and
Methods. Minimal nonspecific gold labeling occurs at tight junctions in empty pCB6 vector cells (a). Gold label appears at tight junction
fibrils in HOC- (b) and CX/OC-transfected cells (c and d). Immunolabeling of CX/OC was also observed at gap junctionlike plaques (d,
arrow). Conventional freeze-fracture of CX/OC-expressing cells using 2% glutaraldehyde (f) revealed distinct connexonlike particles
within the fused fibrils of the tight junction. Such particles are not visible in glutaraldehyde fixed control (empty pCB6) cells (e). Bar:
(a–d) 0.11 mm; (e and f) 0.16 mm. 
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them, we employed immunogold labeling of freeze-frac-
ture replicas. Control cells expressing pCB6 vector alone
showed no specific labeling at tight junction fibrils (Fig. 3
a). In contrast, cells expressing full-length human occludin
(HOC) (Fig. 3 b) or CX/OC (Fig. 3, c and d) both showed
specific labeling along fibrils. Note that in CX/OC-con-
taining cells, a two-dimensional crystalline lattice reminis-
cent of gap junctions is also labeled (Fig. 3 d, arrow), indi-
cating that chimeras expressed at high levels can also
assemble into gap junctionlike aggregates. The increased
gold labeling in CX/OC cells versus human occludin cells
is probably due to higher protein expression in the CX/OC
cells, as documented by immunoblotting (data not shown). 
It has long been known that fixation of cells with glu-
taraldehyde will transform the linear junction particles
into continuously fused fibrils (van Deurs and Luft, 1979).
Whereas unfixed particles appear on the ectoplasmic face,
fixed fibrils appear on the P-face as continuous strands in-
terspersed with occasional hemispherical particles (Stae-
helin, 1973; van Deurs and Luft, 1979). The proportion of
particles to strands varies depending on cell type. In con-
trast, gap junctions visualized by freeze-fracture in glu-
taraldehyde fixed cells never fuse but always appear as
large, paracrystalline aggregates of discrete connexon par-
ticles on the P-face. Interestingly, in CX/OC-expressing
cells fixed in 2% glutaraldehyde and processed for con-
ventional freeze-fracture, distinct particles similar in size
and shape to connexons are visible within the fused fibrils
of the P-face (Fig. 3 f), but are absent in cells transfected
with HOC (data not shown) and the control empty vector
(Fig. 3 e). These particles, which presumably represent the
connexin portion of CX/OC, occur in perfect register with
the rest of the fibril. Similar morphological changes are
not apparent in the immunogold-labeled replicas because
the relatively brief, gentle fixation of 1% formaldehyde
used in the gold labeling was not sufficient to fuse the
fibrils. Together, these results strongly suggest that the
CX/OC chimera is intercalated directly into junctional
fibrils.
To determine whether the CX/OC chimera was within
or just near fibrils, we next quantified the orthogonal dis-
tance between individual gold particles and the nearest
fibril. Transfected, epitope-tagged occludin was assumed
to be incorporated into fibrils and was used as a control
reference. Both occludin and the CX/OC chimera show
similar distance distributions from fibrils, with the most
common distance ranging from 6–12 nm (Fig. 4). This dis-
tance corresponds roughly to the length of the intervening
primary and secondary antibodies used in the labeling pro-
cedure (Staehelin, 1973). Thus, the CX/OC chimera local-
ized directly within the tight junction fibril, presumably in-
terspersed with endogenous occludin and claudin family
molecules, and without obviously disrupting normal junc-
tion morphology.
 
The ZO-binding Domain Is Necessary for Connexin 
Chimeras to Localize at Tight Junctions
 
We next asked whether the ZO-binding domain is neces-
sary for localization of connexin chimeras at tight junc-
tions. In MDCK cells stably expressing DOC, which con-
tains the ZO-binding domain, VSV-G labeling occurred at
the tight junction (Fig. 5 a), as seen by its colocalization
with endogenous ZO-1 (Fig. 5 b). However POC, which
lacks the ZO-binding domain, localized predominantly in
discrete puncta (Fig. 5 c), similar to gap junctionlike struc-
tures seen with full-length connexin 32 (Fig. 2 a). ZO-1 at
the tight junction (Fig. 5 d) was visible in a more apical fo-
cal plane than POC immunoreactivity. These results sug-
gest that potential interactions between endogenous oc-
Figure 4. Quantitation of gold label distance from freeze-frac-
ture fibrils. The distance from the center of each gold particle to
the center of the nearest fibril was measured using dial calipers
accurate to 0.02 mm. The majority of HOC and CX/OC are both
located 6–12 nm from a fibril, suggesting that CX/OC is incorpo-
rated directly into occludin-containing tight junction fibrils. 
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cludin and transfected POC in the juxtamembrane region
(amino acids 266–372) do not confer tight junction local-
ization to POC. In addition, these results suggest that only
the ZO-binding region of occludin is necessary to localize
a connexin chimera at the tight junction.
 
Endogenous Occludin Is Not Required to Colocalize 
Connexin-Occludin Chimeras with ZO-1 at NRK Sites 
of Cell Contact
 
If an interaction with ZO proteins is independently suffi-
cient to localize occludin in the absence of endogenous oc-
cludin and claudin, we predict that connexin-occludin chi-
meras will be able to localize to ZO-1–containing cell–cell
contacts, even in cells lacking these transmembrane tight
junction proteins. We tested this prediction in NRK fibro-
blasts that express ZO-1 and ZO-2 at cadherin-based
contacts (Itoh et al., 1993) but lack immunodetectable
occludin, claudin-1 and-2 (data not shown) and lack freeze-
fracture fibrils. In support of this prediction is our previ-
ously published observation that full-length occludin stably
expressed in NRK cells colocalizes with ZO-1 at cell–cell
contacts (Van Itallie and Anderson, 1997). In contrast,
occludin lacking the ZO-binding domain does not localize in
NRK cells, yet the same construct localizes to tight junctions
in MDCK cells (Van Itallie, C., personal communication).
When cx32 is transiently expressed in NRK cells its lo-
calization depends on whether adjacent cells also express
the protein. In isolated cells that are not in contact with
other transfected cells, the protein is detected diffusely
in the cytoplasm or in perinuclear aggregates (data not
shown). In contrast, when adjacent cells both express cx32,
it localizes at cell contacts between them (Fig. 6 a, arrow-
head), but not at the contacts with neighboring, nontrans-
fected cells (Fig. 6 a, arrows). cx32 contacts in adjacent
transfected cells occasionally appeared to overlap ZO-1
immunoreactivity (Fig. 6 b), but were quite different in
shape and size. These results suggest that clustering of
cx32 at cell–cell contacts in NRK cells requires expression
of cx32 on both cells and that cx32 has no inherent ten-
dency to associate with ZO-1 at cell contacts.
In contrast, CX/OC (Fig. 6 c) colocalized with ZO-1
(Fig. 6 d) at cell–cell contacts, implying that endogenous
occludin or claudins are not necessary for targeting to ZO-
1–containing cell contacts. This behavior is distinct from
that seen with cx32, which only localized at contacts be-
tween two transfected cells (Fig. 6, a and b). Consistent
with this is the observation that full-length occludin ex-
pressed in NRK cells will colocalize with ZO-1 at cell con-
tacts even when the adjacent cell does not express occlu-
din (Van Itallie, C., personal communication).
Since endogenous occludin is not necessary for localiza-
Figure 5. Immunolocalization
of DOC and POC chimeras
in MDCK cells. DOC (a),
which contains the ZO-bind-
ing region, colocalizes prima-
rily with ZO-1 (b) at tight
junctions and also occasion-
ally at discrete puncta on the
lateral surface. Note that
continuous circumferential
VSV-G staining appears
even in cells that neighbor
nonexpressing cells. POC (c),
which lacks the ZO-binding
site, does not colocalize with
ZO-1 (d). Instead it appears
as puncta around the periph-
ery of the cell in a focal plane
basal to ZO-1, similar to cx32
(Fig. 2). Bar, 30 mm. 
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Figure 6. Immunolocalization
of connexin-occludin chime-
ras in NRK fibroblasts. cx32
localizes at sites of shared
contact between two trans-
fected cells (a, arrowhead),
but does not localize at sites
of cell–cell contact with un-
transfected cells (a, arrows).
ZO-1 immunolabeling occa-
sionally overlaps cx32 local-
ization, but is usually differ-
ent in size and shape (b).
Chimeras containing the ZO-
binding site, CX/OC (c) and
DOC (e), colocalize with
ZO-1 (d and f, respectively)
at fingerlike sites of cell con-
tact around the periphery of
occludin null NRKs. POC
(g), which lacks the ZO-
binding domain, only local-
izes at the plasma membrane
if it is expressed in a cell ad-
jacent to another transfected
cell (g, arrowhead). ZO-1 im-
munolabeling in POC-trans-
fected cells (h) is distinct
from VSV-G immunolabel-
ing. Note the lack of VSV-G
immunoreactivity at other
ZO-1–containing cell con-
tacts in POC-expressing cells
(g, arrows). Bar, 30 mm. 
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tion of connexin-occludin chimeras in NRK cells, we next
tested the requirement for the ZO-binding domain. DOC
(Fig. 6 e) colocalized with ZO-1 (Fig. 6 f) in NRK cells.
However, POC (Fig. 6 g), which lacks the ZO-binding do-
main, did not (Fig. 6 h). Instead, it localized only at con-
tacts between adjacent transfected cells (Fig. 6 g, arrow-
head) and not between adjacent, nontransfected cells (Fig.
6 g, arrows). This is a pattern identical to that seen with
full-length cx32. Thus, the region of occludin that binds
ZO MAGUKs is sufficient to target connexin-occludin
chimeras to cell contacts in cells that do not contain en-
dogenous occludin or claudins. Further, these results sug-
gest that occludin need not bind occludin on an adjacent
cell (transcellular interactions) to enter the contact.
 
Discussion
 
We present evidence that the ZO-binding domain of oc-
cludin’s cytoplasmic tail is sufficient to target connexin-
occludin chimeras to the tight junction and organize them
into the linear fibrils that create the paracellular barrier. In
fibroblasts, which lack endogenous occludin and claudins,
the ZO-binding domain is also sufficient to localize chime-
ras to ZO-1–containing cell contacts. Extrapolating these
results to occludin suggests interactions with ZO proteins
are important for organizing occludin in tight junction
fibrils. This conclusion is different from, but not in conflict
with, that of previous studies that focused on the in-
tramembrane and extracellular regions of occludin, and
concluded that the cytoplasmic tail plays no role in local-
ization. We suggest further study of cytoplasmic scaffold-
ing is important since these connections may ultimately be
most responsible for initial fibril assembly and subsequent
barrier regulation.
We demonstrate using immunogold freeze-fracture la-
beling that connexin fused to the cytoplasmic tail of occlu-
din intercalates directly into the occludin- and claudin-
containing tight junction fibrils. This conclusion is further
supported by the observation that tight junction fibrils in
cells stably expressing CX/OC appear dotted, even after
fixation with glutaraldehyde, with individual particles.
This response to fixation is characteristic of connexin, but
not of occludin (van Deurs and Luft, 1979). Although gap
junctions have been reported near or in continuity with
tight junctions, they are always confined to the regions
around the fibrils and are not found in continuity with
them. In addition, although cx43 is reported to bind ZO-1 in
cardiac myocytes (Toyofuku et al., 1998), cx32 is not
known to form hemichannels with cx43. Moreover, MDCK
cells do not contain cx43 (Jordan et al., 1999).
Further, our chimeric protein approach narrowed this
targeting region to occludin’s COOH-terminal 150–amino
acids, designated the ZO-binding domain; DOC localizes
at the tight junction in MDCK cells and at cell contacts in
NRK fibroblasts. In contrast, chimeras that contain the
membrane proximal region of the occludin cytoplasmic
tail (POC) localize in MDCK cells exclusively to gap junc-
tionlike plaques or to intracellular aggregates. In NRK fi-
broblasts POC localizes, as does full-length connexin 32,
to plaques between neighboring transfected cells. To-
gether, these data strongly suggest that the ability to bind
ZO proteins is necessary and sufficient to localize con-
nexin-occludin chimeras in tight junction fibrils and fibro-
blast cell contact sites.
Previous studies have demonstrated the ability of occlu-
din lacking the ZO-binding domain to target to tight junc-
tions in cultured MDCK cells (Balda et al., 1996) and 
 
Xe-
nopus
 
 embryos (Chen et al., 1997). Balda et al. (1996)
observed that occludin truncated after the fourth mem-
brane-spanning region, and, thus, lacking the ZO-binding
region, was able to localize to tight junctions. Similarly,
Chen et al. (1997) reported tight junction localization in
 
Xenopus
 
 embryos of an occludin construct missing almost
the entire COOH-terminal cytoplasmic domain. These au-
thors demonstrated the coimmunoprecipitation of endog-
enous and truncated transfected occludin, suggesting the
possibility that tight junction targeting of truncated occlu-
din resulted from an association with endogenous occludin
through its transmembrane and/or extracellular regions
(Chen et al., 1997). Interestingly, Furuse et al. (1998b) re-
cently demonstrated that claudin-1 and -2 can recruit oc-
cludin to fibrillike structures in L-cells; thus, interactions
between transmembrane proteins are clearly important
for occludin localization. Alternately, it is also possible
that the transfected claudins recruited ZO proteins, which
then functioned to localize occludin. Nonetheless, the ap-
parent dispensability of the ZO-binding region in the lo-
calization of truncated occludin in these previous studies
may be due to the ability of truncated occludin to self-oli-
gomerize with full-length occludin (Chen et al., 1997) or
co-oligomerize with claudins, either of which are already
interacting with plaque proteins.
In contrast to our data, Matter and Balda (1998) re-
cently demonstrated that the entire COOH-terminal tail
of occludin targets Fc chimeras to the basolateral surface
but is not sufficient to localize them at tight junctions. The
chimeras reported by Matter and Balda (1998) and those
used in this study differ in two respects: this study used the
human occludin sequence, whereas Matter and Balda
(1998) used chicken’s, and the NH
 
2
 
-terminal region of the
Fc protein used by Matter and Balda (1998) is a single
span protein with no known ability to aggregate, whereas
cx32 oligomerizes to form multisubunit connexons. As hu-
man and chicken occludin are only 35.3% identical across
the entire COOH-terminal tail and 44.9% identical be-
tween ZO-binding domains, it is possible that species-spe-
cific sequence differences contributed to our contrary
results. However, chimeras containing the entire COOH-
terminal human occludin tail fused to the extracellular and
membrane-spanning domains of glycophorin C, a single
span transmembrane protein unable to oligomerize, local-
ized basolaterally, not junctionally, in MDCK cells, and
did not colocalize with ZO-1 in NRK cells (Mitic, L., E.
Schneeberger, and J.M. Anderson, unpublished data).
Similar results were obtained using the COOH-terminal
150–amino acids of human occludin fused to the amino
half of glycophorin C. Thus, it is possible that retention of
occludin chimeras at tight junctions and cell contacts re-
quires an NH
 
2
 
 terminus capable of aggregation. cx32 may
be able to substitute functionally for occludin in this re-
spect.
Our results indicate that connexin can be aligned side-
by-side with occludin into ordered, linear fibrils when it is
fused to the ZO-binding region, thus, suggesting a scaf- 
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folding function for ZO-1, ZO-2, or ZO-3. The ZO pro-
teins are members of the MAGUK protein family, many
of whose members have already been shown to function as
cytoplasmic scaffolds in organizing membrane proteins into
specialized membrane domains (for review see Anderson,
1996; Fanning and Anderson, 1996). Genetic evidence
from invertebrates supports this idea. For example, in
 
Caenorhabditis elegans
 
 loss of LIN-2, a MAGUK, results
in membrane mislocalization of the LET-23 receptor ty-
rosine kinase, a subsequent lack of receptor activation
during development and a vulvaless phenotype (Simske et
al., 1996). In 
 
Drosophila
 
, the Discs-large MAGUK binds
Shaker-type K
 
1 
 
channels at neuromuscular junctions (Te-
jedor et al., 1997). Mutations in Discs-large are associated
with a loss of Shaker-type K
 
1
 
 channels from the neuro-
muscular junctions and their redistribution over the plasma
membrane (Tejedor et al., 1997). Likewise, a vertebrate
MAGUK called postsynaptic density protein-95 kD (PSD-95)
has also been demonstrated in vertebrate synapses to bind
and cluster both the 
 
N
 
-methyl-
 
D
 
-aspartate receptor and
the Shaker-type K
 
1
 
 channel (Kim et al., 1995; Kornau et
al., 1995). Thus, the precedent for MAGUK involvement in
organizing membrane proteins at specialized surface do-
mains is well established.
MAGUK protein family members are characterized by a
multidomain organization that includes one or three PSD-95/
Discs-Large/ZO-1(PDZ) domains (for review see Fanning
and Anderson, 1996; Fanning et al., 1996). PDZ domains
are 80–100-amino acid protein binding cassettes that rec-
ognize a three residue peptide motif in the COOH termini
of their binding partners (Songyang et al., 1997). MAGUK
proteins also serve as linkers between integral membrane
proteins and cytoskeletal networks. For example, p55, a
MAGUK protein that contains one PDZ, anchors the
transmembrane protein glycophorin C and also binds pro-
tein 4.1 (Marfatia et al., 1995). Similarly, the human homo-
logue of the 
 
C
 
.
 
 elegans
 
 protein Lin-2, a MAGUK protein,
likely ties the membrane protein syndecan-2 to the cyto-
skeleton via the actin-binding protein 4.1. Recently, ZO-1
has been reported to bind directly to actin in fibroblasts
via its proline-rich COOH terminus (Itoh et al., 1997).
Likewise, ZO-1 itself appears to directly link occludin to
actin (Fanning et al., 1998), suggesting that it may mediate
cytoskeletally induced changes in occludin’s sealing prop-
erties. Of note, members of the claudin family contain
PDZ-binding motifs at their COOH termini.
Our results together with previously published data sug-
gest the possibility of multiple steps for the assembly of oc-
cludin into fibrils. Free occludin in the lateral plasma
membrane concentrates at the tight junction via contacts
with a preformed, cytoplasmic ZO-containing scaffold. Con-
comitant  self-aggregation, or oligomerization with other
transmembrane proteins such as claudins, is necessary to
assemble and/or maintain occludin in linear fibrils. Incor-
poration into a fibril could be regulated at either of these
two steps: binding to ZOs or oligomerization. This idea is
consistent with the recent observation of a second pool of
occludin that is present on the lateral cell surface and not
organized into fibrils (Sakakibara et al., 1997). The junc-
tional pool of occludin is hyperphosphorylated relative to
the nonfibrillar pool, suggesting phosphorylation might be
one mechanism for regulating assembly (Sakakibara et al.,
1997). Lending further support for this model, ZO-1 is lo-
calized at cell–cell contacts in the absence of occludin,
such as in the NRK fibroblasts used in this study, but no
examples of occludin localization in the absence of ZO-1
are known.
Several published experimental observations suggest
cadherin is the initial organizer of the tight junction
plaque. First, extracellular antibodies against cadherin in-
hibit formation of tight junctions (Gumbiner et al., 1988;
Balda et al., 1991). Second, the tight junction and the ad-
herens junction may be physically linked, particularly dur-
ing formation of the tight junction, via ZO-1, which binds
the cadherin-associated proteins 
 
a
 
- (Itoh et al., 1997) and
 
b
 
-catenin (Rajasekaran et al., 1996). Moreover, cells con-
taining a mutant form of 
 
a
 
E-catenin that is unable to bind
vinculin do not localize ZO-1 at tight junctions or form
continuous fibrils (Watabe-Uchida et al., 1998). Lastly,
ZO-1 assembles at cell–cell contacts before occludin and
coincident with E-cadherin in studies of tight junction for-
mation in the early mouse embryo (Sheth et al., 1997).
These observations, together with those reported here,
suggest that occludin is recruited into a preformed ZO-
containing structure whose assembly is initiated at the ad-
herens junction. We have demonstrated that the ZO-bind-
ing domain is sufficient for localization in fibrils. Such a
model implies that regulation of the tight junction barrier
may occur through reversible recruitment of occludin into
fibrils organized by a ZO-containing scaffold. The occlu-
din–ZO interactions and the overall organization of the
cytoplasmic plaque will be important subjects of future in-
quiry into the assembly and regulation of tight junctions.
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